about
Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.Caveolin-1 modifies the immunity to Pseudomonas aeruginosaThe NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potentialLipid raft redox signaling: molecular mechanisms in health and disease.Ceramide-rich platforms in transmembrane signaling.Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.SrfJ, a Salmonella type III secretion system effector regulated by PhoP, RcsB, and IolR.Recent developments in the interactions between caveolin and pathogens.Roles and regulation of secretory and lysosomal acid sphingomyelinase.Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.Functional Rescue of F508del-CFTR Using Small Molecule CorrectorsAltered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme DeliveryA Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.Linoleic acid supplement in cystic fibrosis: friend or foe?Triggering of dendritic cell apoptosis by xanthohumol.Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages.How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection.
P2860
Q30582564-056F0530-96E1-4A0E-A911-71E0483E8AB5Q33979216-EE31B786-D2ED-41DC-B2C2-67E99AF3B742Q35043484-4CFA3D04-AE95-4861-A766-BC7862081502Q35101890-835150E6-7E2B-4C25-A06F-469B3E052E09Q35633883-4796006B-F083-4C9F-B447-D489785EC0CDQ35828043-2C169501-3BD5-4959-AD4A-2EB4C8624024Q36155240-4FFD10A5-9FE8-4DEE-9BA6-6A88FF54C782Q36586691-5996C911-19A6-417D-901D-39DB2548E608Q37454661-1F00D528-13A7-462B-B284-171B8035A781Q37514889-15BF27D2-3DBE-42CA-BDED-4485CF466EA4Q38051325-A17F04A2-A2E2-46D0-B542-699632A8DB87Q41035019-E917311C-7BB1-4FDE-AB21-7BCF7A413703Q41829569-5BC49B27-7655-4A3D-ABAA-C03188FCDEDDQ42365367-9312D3ED-3EE0-4E2D-9FDB-E130E6DA287FQ43120232-3BADDEB9-E038-4098-8B26-9FF7A065B058Q46089617-37D254DC-F677-4D13-95A2-A2DA645EAABBQ47276739-E5C36FAD-D2F9-4F61-BE34-90C16F892AC9Q49972804-A4A01D4C-769D-4571-B8D8-9975F479F6A4
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Ceramide in bacterial infections and cystic fibrosis.
@en
Ceramide in bacterial infections and cystic fibrosis.
@nl
type
label
Ceramide in bacterial infections and cystic fibrosis.
@en
Ceramide in bacterial infections and cystic fibrosis.
@nl
prefLabel
Ceramide in bacterial infections and cystic fibrosis.
@en
Ceramide in bacterial infections and cystic fibrosis.
@nl
P2860
P50
P356
P1433
P1476
Ceramide in bacterial infections and cystic fibrosis.
@en
P2093
Yang Zhang
P2860
P304
P356
10.1515/BC.2008.162
P577
2008-11-01T00:00:00Z